Research Topics
| W J ElliottSummaryAffiliation: Rush University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Calcium channel blockersWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Rush University, Chicago, IL, USA
J Clin Hypertens (Greenwich) 13:687-9. 2011..Diltiazem and verapamil have important drug interaction with digoxin and cyclosporine, among others...
Optimizing medication adherence in older persons with hypertensionWilliam J Elliott
The Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
Int Urol Nephrol 35:557-62. 2003..Improving medication adherence would be a simple way to make antihypertensive therapies much more cost effective, since a medication that is not taken incurs all of cost, and provides no benefit to the patient...
Management of hypertension in the very elderly patientWilliam J Elliott
Department of Preventive Medicine, Rush University Medical Center, 1700 W Van Buren, Suite 470, Chicago, IL 60612, USA
Hypertension 44:800-4. 2004..Its choice of a diuretic as initial therapy is consistent with other trials, but chlorthalidone is the drug with the most compelling evidence in large US trials that included very elderly patients...
PrehypertensionWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
Nat Clin Pract Cardiovasc Med 4:538-48. 2007..In this Review, we attempt to summarize the recently published data concerning the epidemiology, attendant risks and potential treatment options for this important and growing public-health problem...
The role of calcium antagonists in stroke preventionWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 7:5-8. 2005..The risk of heart failure, however, is significantly increased (by 29%) with the initial calcium antagonist. These estimates may change as newer trials are reported...
Differential effects of antihypertensive drugs on new-onset diabetes?William J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
Curr Hypertens Rep 7:249-56. 2005..An earlier diagnosis of diabetes mellitus generally has little impact (over 5 years) on cardiovascular risk. The clinical importance of differential effects of antihypertensive drugs on incident diabetes is, therefore, much less clear...
Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitorsWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 7:2-4. 2005..Although angiotensin-converting enzyme inhibitors can cause cough and angioedema (more common among blacks), angiotensin receptor blockers are currently more expensive and have fewer outcome trials to support their use...
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patientsWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 7:654-63. 2005....
Clinical features in the management of selected hypertensive emergenciesWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Rush University, Rush University Medical Center, Chicago, IL 60612, USA
Prog Cardiovasc Dis 48:316-25. 2006..Long-term follow-up to ensure adequate control of hypertension is necessary to prevent further target-organ damage and recurrence of another hypertensive emergency...
Drug interactions and drugs that affect blood pressureWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 8:731-7. 2006....
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapiesWilliam J Elliott
Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL, USA
J Am Board Fam Med 20:72-80. 2007..To assess 1-year persistence and adherence with monotherapy using the most commonly dispensed individual agent in 4 antihypertensive drug classes: hydrochlorothiazide (HCTZ), amlodipine, lisinopril, or valsartan...
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysisWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
Lancet 369:201-7. 2007..We therefore undertook a network meta-analysis, which accounts for both direct and indirect comparisons to assess the effects of antihypertensive agents on incident diabetes...
A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplaceWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Chicago, IL 60612, USA
Blood Press Monit 12:23-8. 2007....
Device-guided breathing to lower blood pressure: case report and clinical overviewWilliam J Elliott
Rush Medical College, Chicago, Illinois, USA
MedGenMed 8:23. 2006..Device-guided paced breathing may offer an effective, simple, and new nonpharmacologic option for treating high BP without additional side effects, but like all lifestyle modifications, must be practiced consistently to provide benefits...
Renovascular hypertension: an updateWilliam J Elliott
Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 10:522-33. 2008....
Management of hypertension emergenciesWilliam J Elliott
RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
Curr Hypertens Rep 5:486-92. 2003..When properly treated, "malignant hypertension" need be considered malignant no longer...
Is fixed combination therapy appropriate for initial hypertension treatment?William J Elliott
Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
Curr Hypertens Rep 4:278-85. 2002....
Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockersW J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
Curr Hypertens Rep 2:402-11. 2000..Many longer-term outcome studies with survival endpoints are under way, but most will compare the combination against an ACE inhibitor alone. These studies will define the optimal use of these agents in medicine for decades to come...
Hypertensive emergenciesW J Elliott
Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
Crit Care Clin 17:435-51. 2001..Because of advances in antihypertensive therapy and management, "malignant hypertension" should be truly malignant no longer...
Cyclic and circadian variations in cardiovascular eventsW J Elliot
Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
Am J Hypertens 14:291S-295S. 2001..Individuals who work night shifts and those whose BP has a different circadian pattern have a higher risk of cardiovascular events, but may be less likely to have an increased risk of cardiovascular events in the morning...
Treatment of hypertension in the elderlyWarren J Elliott
Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
Am J Geriatr Cardiol 11:11-20; quiz 20-2. 2002..Future cardiovascular risk may be related directly to the blood pressure attained, rather than to how it was attained...
Timing treatment to the rhythm of disease. A short course in chronotherapeuticsW J Elliott
Rush Medical College, Rush University, Chicago, USA
Postgrad Med 110:119-22, 125-6, 129. 2001..Results of the ongoing CONVINCE study may provide evidence that chronotherapy for hypertension and angina pectoris may be more effective than traditional homeostatic treatment...
The economic impact of hypertensionWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University, Rush Presbyterian St Lukes Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 5:3-13. 2003..Pharmacoeconomic analyses regarding antihypertensive drug therapies, their costs, and the relevant reductions in health care expenditures are a useful framework for optimizing current strategies for hypertension management...
Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke preventionKenneth L Choi
Department of Preventive Medicine, Rush Medical College, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
Curr Hypertens Rep 7:367-73. 2005..Therefore, for cardiovascular end points (as opposed to renal end points), it may be more important that the blood pressure is reduced, rather than how the process is started...
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott
Rush-Presbyterian/St Luke's Medical Center, Chicago, Illinois, USA
Clin Ther 23:1166-79. 2001..Losartan, but not valsartan, was associated with a decrease in serum uric acid levels...
One-year study of felodipine or placebo for stage 1 isolated systolic hypertensionH R Black
Department of Preventive Medicine, Rush Medical College of Rush University at Rush Presbyterian Saint Luke s Medical Center, Chicago, Illinois, USA
Hypertension 38:1118-23. 2001..Larger and longer studies will be needed to document any long-term reduction in cardiovascular event rates associated with treating stage 1 systolic hypertension...
Circadian variation in blood pressure: implications for the elderly patientW J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University and Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA
Am J Hypertens 12:43S-49S. 1999....
Detection, treatment, and control of adult hypertension in northwest Indiana. Ispat Inland/United Steelworkers of America Health Care NetworkW J Elliott
Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA
Am J Hypertens 12:830-4. 1999....
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical regionHenry R Black
Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois 60612, USA
J Hypertens 23:1099-106. 2005..To examine regional differences in the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial...
What factors contribute to the inadequate control of elevated blood pressure?William J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612 3244, USA
J Clin Hypertens (Greenwich) 10:20-6. 2008..Single-pill, or fixed-dose, combination therapy is one approach that improves adherence, while also providing the antihypertensive efficacy needed to help patients achieve their blood pressure goals...
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialHenry R Black
Rush Medical College of Rush University, Chicago, IL 60612, USA
JAMA 289:2073-82. 2003..Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial...
Hypertension in women: the Women Take Heart projectA lice A Furumoto-Dawson
Department of Preventive Medicine, Rush Medical College, Rush-Presbyterian-St Lukes Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 5:38-46. 2003..1% of self-reported hypertensives. Results from this study and national surveys indicate that hypertension detection and control remain major public health challenges in preventing cardiovascular disease in older women...
Clinical features and management of selected hypertensive emergenciesWilliam J Elliott
Department of Preventive Medicine, Rush Medical College of Rush University, Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 6:587-92. 2004..Because of advances in antihypertensive therapy and management, "malignant hypertension" should be malignant no longer...
Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?Nitin Khosla
Department of Preventive Medicine, Rush Hypertension/Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 7:354-6. 2005
Resistant hypertension revisited: a comparison of two university-based cohortsJay P Garg
Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, 60612, USA
Am J Hypertens 18:619-26. 2005....
Systemic hypertensionWilliam J Elliott
Rush Medical College, Rush University Medical Center, Chicago, USA
Curr Probl Cardiol 32:201-59. 2007..Special circumstances exist for treatment of hypertension in pregnancy, in childhood, in the elderly, and in both extremes of blood pressure (pre-hypertension or hypertensive emergencies)...
Compliance--and improving it--in hypertensionWilliam J Elliott
Rush Medical College, Chicago, USA
Manag Care 12:56-61. 2003..Compliance and persistence rates vary by drug class, but clinicians can take practical steps to improve patient adherence to any prescribed regimen. JNC-7 recognizes barriers to physician compliance with treatment recommendations...
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentMichael L Maitland
Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA
Clin Cancer Res 15:6250-7. 2009..This prospective, single-center, cohort study characterized ambulatory blood pressure monitoring as an early pharmacodynamic biomarker of VEGF signaling pathway inhibition by sorafenib...
Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapyWilliam J Elliott
Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL 60612, USA
J Clin Hypertens (Greenwich) 11:376-82. 2009..More widespread use of such agents, particularly those available in generic formulations or in low-cost formularies, may lead to better long-term BP control and fewer cardiovascular events...
Blood pressure reduction is not the only determinant of outcomePeter S Sever
International Centre for Circulatory Health, Imperial College London, 59 N. Wharf Rd, London, W2 1PG, UK
Circulation 113:2754-72; discussion 2773-4. 2006
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SRFranz Messerli
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University, New York, NY, USA
Blood Press Suppl 1:6-9. 2007..Despite differences in the risk profiles of previously studied patients and INVEST patients, the antihypertensive effects of Ve+Tr were similar...
Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot studyJay P Garg
Division of Nephrology, Department of Medicine, University of California San Francisco, USA
Am J Nephrol 25:393-9. 2005..Because angiotensin II may have adverse effects on the arterial wall, we hypothesized that an angiotensin receptor blocker (ARB) would improve arterial compliance as compared with placebo in subjects with CKD...
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluationThomas J Hogan
MEDTECH, Morristown, New Jersey 07960, USA
Pharmacoeconomics 20:37-47. 2002..To conduct an economic analysis in the US of antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency...
Chlorthalidone vs other low-dose diureticsKenneth L Choi
JAMA 292:1816-7; author reply 1817. 2004
Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurementsJoel M Neutel
Orange County Heart Institute and Research Center, Orange, CA 92868, USA
J Clin Hypertens (Greenwich) 4:325-31. 2002..The safety profile of olmesartan medoxomil was similar to that of placebo. Olmesartan medoxomil appears to be a safe and effective once-a-day treatment for hypertension...
How pharmacists can assist physicians with controlling blood pressureBarry L Carter
Department of Family Medicine, Colleges of Pharmacy and Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Hypertens (Greenwich) 5:31-7. 2003..This review summarizes studies involving pharmacist participation in hypertension management and provides recommendations for obtaining pharmacist involvement...
Drug delivery systems for treatment of systemic hypertensionL Michael Prisant
Hypertension and Clinical Pharmacology Unit, Medical College of Georgia, Augusta, Georgia 30912, USA
Clin Pharmacokinet 42:931-40. 2003..Potential advantages include reduced administration frequency, enhanced adherence and convenience, reduced toxicity, stable drug concentrations, uniform drug effect, decreased cost (occasionally) and decreased daily dosage...
